Showing results (561-570 of 1,038) with videos related to

Sort By:
Pageof 104
Neurobiology of Aging|December 3, 2014
Loss of NEIL1 causes defects in olfactory function in miceChandrika Canugovi, Magdalena Misiak, Morten Scheibye-Knudsen, et al.
European Journal of Human Genetics : EJHG|November 8, 2019
A multimodal attempt to follow-up linkage regions using RNA expression, SNPs and CpG methylation in schizophrenia and bipolar disorder kindredsYvon C Chagnon, Michel Maziade, Thomas Paccalet, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 20, 2019
Implementation Research on Shared Decision Making in Primary Care: Inventory of Intracluster Correlation CoefficientsAli Ben Charif, Jordie Croteau, Rhéda Adekpedjou, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 7, 2007
Impact of beta-blocker treatment and nutritional status on glycemic response during exercise in patients with type 2 diabetesAnnie Ferland, Patrice Brassard, Sara Croteau, et al.
BMJ Open Sport & Exercise Medicine|August 2, 2017
Physical activity during pregnancy and infant's birth weight: results from the 3D Birth CohortMichèle Bisson, Jordie Croteau, Benjamin C Guinhouya, et al.
Human Heredity|July 23, 2009
A new strategy for linkage analysis under epistasis taking into account genetic heterogeneityAlexandre Bureau, Chantal Mérette, Jordie Croteau, et al.
The Journal of Biological Chemistry|April 6, 2006
UvrB domain 4, an autoinhibitory gate for regulation of DNA binding and ATPase activityHong Wang, Matthew J DellaVecchia, Milan Skorvaga, et al.
Pediatric Obesity|June 7, 2013
Replication of LIN28B SNP association with age of menarche in young Filipino womenD C Croteau-Chonka, L A Lange, N R Lee, et al.
Human Heredity|August 22, 2012
Detection of phenotype modifier genes using two-locus linkage analysis in complex disorders such as major psychosisAlexandre Bureau, Jordie Croteau, Chantal Mérette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levelsG Batist, F Patenaude, P Champagne, et al.
Pageof 104